Satterley & Kelley PLLC
Know Your Rights. Call 800-655-2117For A Free Initial Consultation.

mesothelioma Archives

The role empathy plays in treating terminally ill patients

Kentucky residents with friends or family members who have been diagnosed with mesothelioma know how devastating this diagnosis can be. This is a rare form of cancer that is related to asbestos. It is aggressive, and there is no known treatment for the disease. The medical community is working hard to find ways to improve survival rates and to improve a sufferer's quality of life. Recent research suggests that physicians should also pay more attention to what they say and how they go about speaking with patients who have been diagnosed with this disease.

Pembrolizumab not the hoped-for "miracle drug" for mesothelioma

Malignant pleural mesothelioma is an aggressive form of cancer often linked with on-the-job asbestos exposure. There is no cure, and there are few treatment options available. Only one drug, Alimta, has been approved for treatment. Louisville residents should be aware that researchers were looking for a while to a drug called pembrolizumab as a possible "miracle drug" for the cancer.

Study finds certain types of mesothelioma respond to chemo

A new study shows that determining the specific type of cancer cells that mesothelioma patients in Louisville and other areas have in their bodies could help improve their prognosis. The study was conducted by researchers at the University of Pennsylvania, Yale and the M.D. Anderson Cancer Center at The University of Texas.

TTFields treatment for mesothelioma shows promise

Louisville residents with mesothelioma are usually treated by way of chemotherapy. There is another treatment, though, that the FDA has approved for use alongside chemotherapy called TTFields, or Tumor Treating Fields. The treatment makes use of electric fields that disrupt the division of mesothelioma tumor cells, possibly keeping them from spreading uncontrollably.

Johnson & Johnson to pay $37.3 million in talc lawsuit

In early September, the drug giant Johnson & Johnson was ordered to pay out $37.3 million on yet another cancer case relating to the asbestos found in a talc-based baby powder. Louisville residents should know that the four plaintiffs allegedly used the baby powder and developed mesothelioma as a result: a rare, aggressive cancer with few effective treatment options.

New drug may help relapsed pleural mesothelioma patients

Many pleural mesothelioma patients undergo immunotherapy, but some will relapse. Louisville residents should know that there is a drug called vorinostat that may help relapsed patients. This is according to a study from Tampa's Moffitt Cancer Center. Vorinostat is an inhibitor of the enzyme histone deacetylase and can change protein expression in cells as well as boost the immune system.

Chemotherapy improves survival time for mesothelioma patients

Treatment options exist in Kentucky that have the potential to increase survival times for people with mesothelioma. Chemotherapy centered around the drug Alimta has become the standard course of treatment for mesothelioma patients, but a study of 910 people with the disease showed that older patients received this treatment less often than younger people with the diagnosis.

Risk of peritoneal mesothelioma may remain for decades

A study by university researchers indicates that the risk for a certain type of mesothelioma never drops once the person has been exposed to asbestos. People in Louisville who have previous exposure to asbestos might be interested in the findings, which showed that pleural mesothelioma risk might level off over the course of decades, but the risk of peritoneal mesothelioma is never reduced. Even after more than 40 years following exposure, the risk continues to grow.

How mesothelioma affects women

Mesothelioma has always been rarer among women than among men, but the incidence rate among women is still nothing to ignore. While there are 1.93 cases of mesothelioma per 100,000 men in the U.S., there are 0.41 per 100,000 women. Residents of Louisville should know that the number one cause of mesothelioma in both men and women is asbestos exposure.

Dendritic cell therapy may improve mesothelioma treatments

Various treatments for mesothelioma have been developed, yet none have been found to extend the lives of mesothelioma patients beyond a few months. Residents of Kentucky should know that the use of immune checkpoint inhibitors is also ineffective, the reason being that mesothelioma can keep dendritic cells, which are immune system cells, from activating the T-cells that can attack the cancer.

You do not have to stand alone. Call 855-385-9532 to talk to a lawyer at Satterley & Kelley PLLC in Louisville.

Office Address

8700 Westport Road
Suite 202
Louisville, KY 40242

Toll Free: 800-655-2117
Toll Free: 855-385-9532
Phone: 502-785-8758
Fax: 502-814-5500
Louisville Law Office Map

Office Numbers

Email Us For A Response

Get Help Now

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy